Off-label use of antibiotics in intensive care unit: The multidrug-resistant pathogens challenge

Journal of Critical Care

Volumn 26, Issue 1, 2011, Pages 95-96

  Curcio, Daniel ^a  

^a Instituto Sacre Cour   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPENEM; TIGECYCLINE;

ABDOMINAL INFECTION; ACINETOBACTER; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; ENTEROBACTERIACEAE; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LETTER; MULTIDRUG RESISTANCE; OFF LABEL DRUG USE; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; SKIN INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EVIDENCE-BASED MEDICINE; HUMANS; INTENSIVE CARE UNITS; MINOCYCLINE; OFF-LABEL USE; PHYSICIAN'S PRACTICE PATTERNS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79551517586     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2010.10.009     Document Type: Letter

References (9)

1. Lat I., Micek S., Janzen J., et al. Off-label medication use in adult critical care patients. J Crit Care 2011, 26:89-94.
2. Michalopoulos A., Falagas M.E. Treatment of Acinetobacter infections. Expert Opin Pharmacother 2010, 11:779-788.
3. Gazarian M., Kelly M., McPhee J.R., et al. Off-label use of medicines: consensus recommendations for evaluating appropriateness. Med J Aust 2006, 185:544-548.
4. Tygacil prescribing information. ; (Sep 21, 2010, date last accessed). http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021821s025lbl.pdf.
5. Freire A.T., Melnyk V., Kim M.J., et al. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia. Diagn Microbiol Infect Dis 2010, 68:140-151.
6. Curcio D., Fernández F., Duret F. Initial use of tigecycline in Argentina. Rev Chilena Infectol 2007, 24:497-499.
7. Curcio D., Fernández F., Cané A., et al. Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry. Braz J Infect Dis 2008, 12:198-201.
8. Curcio D., Fernández F., Vergara J., et al. Late onset ventilator-associated pneumonia due to multidrug-resistant Acinetobacter spp.: experience with tigecycline. J Chemother 2009, 21:58-62.
9. Curcio D., Castagnino J., Vazquez W., et al. Tigecycline in the treatment of ventilator-associated pneumonia: experience from the Latin American Tigecycline Use Registry. Infez Med 2010, 18:27-34.